Cajeta, Arian .
HRN: 22-34-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/24/2022
12/31/2022
IV
1.2 G
Q6
Periapical Abscess On Molar Tooth (Lower Jaw) Right
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes